5 research outputs found

    Confocal Raman data analysis enables identifying apoptosis of MCF-7 cells caused by anticancer drug paclitaxel

    Get PDF
    Confocal Raman microscopy is a noninvasive, label-free imaging technique used to study apoptosis of live MCF-7 cells. The images are based on Raman spectra of cells components, and their apoptosis is monitored through diffusion of cytochrome c in cytoplasm. K-mean clustering is used to identify mitochondria in cells, and correlation analysis provides the cytochrome c distribution inside the cells. Our results demonstrate that incubation of cells for 3 h with 10 mu M of paclitaxel does not induce apoptosis in MCF-7 cells. On the contrary, incubation for 30 min at a higher concentration (100 mu M) of paclitaxel induces gradual release of the cytochrome c into the cytoplasm, indicating cell apoptosis via a caspase independent pathway. (C) 2013 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.18.5.056010

    Syndecan-4 affects myogenesis via Rac1-mediated actin remodeling and exhibits copy-number amplification and increased expression in human rhabdomyosarcoma tumors

    Get PDF
    Skeletal muscle demonstrates a high degree of regenerative capacity repeating the embryonic myogenic program under strict control. Rhabdomyosarcoma is the most common sarcoma in childhood and is characterized by impaired muscle differentiation. In this study, we observed that silencing the expression of syndecan-4, the ubiquitously expressed transmembrane heparan sulfate proteoglycan, significantly enhanced myoblast differentiation, and fusion. During muscle differentiation, the gradually decreasing expression of syndecan-4 allows the activation of Rac1, thereby mediating myoblast fusion. Single-molecule localized superresolution direct stochastic optical reconstruction microscopy (dSTORM) imaging revealed nanoscale changes in actin cytoskeletal architecture, and atomic force microscopy showed reduced elasticity of syndecan-4-knockdown cells during fusion. Syndecan-4 copy-number amplification was observed in 28% of human fusion-negative rhabdomyosarcoma tumors and was accompanied by increased syndecan-4 expression based on RNA sequencing data. Our study suggests that syndecan-4 can serve as a tumor driver gene in promoting rabdomyosarcoma tumor development. Our results contribute to the understanding of the role of syndecan-4 in skeletal muscle development, regeneration, and tumorigenesis

    Drug-induced changes in nanomechanics of mammalian cells as measured by AFM

    No full text
    International audienceComparative studies on the nanomechanics of normal and malignant cells of the same type are of great importance as they can reveal new information about, and help understanding mechanisms of malignant transformation. In this work, we investigate the morphology and the elastic properties of live cultured, normal human mammalian epithelial cells (HMEC) and breast carcinoma epithelial cells (MCF7), using atomic force microscopy (AFM). We describe the different behaviour of the two similar cell lines under curcumin treatment. Up to a six-hour long treatment leaves the MCF7 cells morphology non-affected, but the microtubules of HMEC cells disassemble and form a ring-like organization circumscribing the nuclear area. The observed morphological changes were correlated to modifications in cell's mechanics via elasticity force-volume measurements. Curcumin treatment modified elasticity of the HMEC cells increasing dramatically the cell's average Young's modulus. Contrariwise, a slight decrease in the Young's modulus value was noticed for the MCF7 cells, as they become softer due to the action of curcumin. This different response of the malignant and non-malignant cells under the same treatment might be of high importance in developing follow-up therapy against breast cancer. Moreover, we also explore the effectiveness of paclitaxel on MCF7 cells. Although paclitaxel is used widely in the treatment of breast cancer, not all tumors respond to this drug, and the characteristics that distinguish resistant tumors from sensitive ones are not well defined
    corecore